Cytology of Ductal Lavage Fluid of the Breast

Diagnostic Cytopathology

Volumn 30, Issue 3, 2004, Pages 143-150

  Ljung, Britt Marie ^a,b   Chew, Karen L ^a   Moore II, Dan H ^a   King, Eileen B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cytology; Ductal lavage fluid

Indexed keywords

ASPIRATION BIOPSY; BREAST CANCER; BREAST DUCT; BREAST DUCTAL LAVAGE; BREAST DUCTAL LAVAGE FLUID; CANCER CLASSIFICATION; CANCER GRADING; CANCER RISK; CATHETER; CELL HYPERPLASIA; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL SIZE; CHROMATIN STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LAVAGE; MAJOR CLINICAL STUDY; NIPPLE; NIPPLE ASPIRATE FLUID; NIPPLE ASPIRATION FLUID; NUCLEOLUS; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

BODY FLUIDS; CYTODIAGNOSIS; EPITHELIAL CELLS; FEMALE; HUMANS; IRRIGATION; MAMMARY GLANDS, HUMAN; MASS SCREENING; NIPPLES;

EID: 1542366328     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20003     Document Type: Conference Paper

References (14)

1. Petrakis NL, Mason L, Lee R. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. J Natl Cancer Inst 1975;54:829-834.
2. Sartorius OW, Smith HS, Morris P, Benedict P, Friesen L. Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst 1977;59:1073-1078.
3. Wynder EL, Lahti H, Laaskso K, Cheng S, DeBevoise S, Rose DP, Nipple aspirates of breast fluid and the epidemiology of breast disease. Cancer 1985;56:1473-1478.
4. Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992;135:130-141.
5. Dooley WC, Ljung B-M, Veronesi U, et al. Ductal lavage and detection of abnormal cytology in women at high risk for breast cancer. (submitted).
6. King EB, Barrett D, King M-C, Petrakis NL. Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol 1975;64:728-738.
7. King EB, Barrett D, Petrakis NL. Cellular composition of the nipple aspirate specimen of breast fluid. II. Abnormal findings. Am J Clin Pathol 1975;64:739-748.
8. Gail MH, Brinton LA, Byar DP et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
9. King EB, Chew KL, Petrakis NL, Ernster VL. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 1983;71:1115-1121.
10. Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 1997;76:494-501.
11. NCI Committee on Breast Fine Needle Aspiration Biopsy. The uniform approach to breast fine-needle aspiration biopsy. Am J Surg 1997;174:371-385.
12. Fabian CJ, Kimler BF, Zalles CM, et al. Short term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000;92:1217-1227.
13. Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698-2708.
14. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-151.